Endocrinology, Vol 116, 1717-1723, Copyright © 1985 by Endocrine Society

ARTICLES

Somatostatin receptors in the rat adrenal cortex: characterization and comparison with brain and pituitary receptors

CB Srikant and YC Patel

Specific receptors for tetradecapeptide somatostatin (S-14) in rat adrenal cortical membranes were quantitated by direct binding studies using [125I-Tyr11]S-14. Competitive inhibition of this radioligand by S- 14 showed that these receptors constitute a single class of high affinity binding sites [dissociation constant (Kd) = 1.08 nM and maximum binding capacity (Bmax) = 0.35 pmol/mg membrane protein]. Structural analogs of S-14 with halogenated Trp8 moiety exhibited 4- to 46-fold greater binding affinity than S-14, [D-F5-Trp8]S-14 being the most potent. [Tyr11]S-14 and [des-Ala1]S-14 bound to these receptors with reduced affinity whereas [Phe4]S-14 exhibited 1.5-fold greater affinity than S-14. Somatostatin-28 (S-28) and S-14 were equipotent, whereas the N-terminal fragments of S-28 [S-28(1-14) and S-28(1-12)] were inactive. High affinity binding sites were also quantitated using a radioligand prepared from the tyrosinated S-28 analog, [Leu8, D- Trp22, Tyr25]S-28 (Kd = 1.2 nM; Bmax = 0.21 pmol/mg membrane protein). Both S-14 and S-28 exhibited comparable relative potencies for inhibiting the specific binding of this radioligand and [125I-Tyr11]S- 14. Extracts of whole adrenal or the adrenal medulla and cortex contained very low levels of S-14-like immunoreactivity (2.4 pg/mg protein). These studies confirm the presence of specific receptors for S-14 in the adrenal cortex and suggest that 1) with respect to S-14 biological activity, Trp8-modified S-14 analogs should be more potent than S-14, S-28 equipotent with S-14, and N-terminal fragments of S-28 inactive in this tissue. 2) Direct binding studies using radioiodinated [Tyr11]S-14 and [Leu8,D-Trp22, Tyr25]S-28 appear to quantitate the same receptor sites in adrenocortical tissue. 3) The ligand specificity of the adrenocortical S-14 receptor differs from that previously reported for the pituitary and brain providing further evidence for the heterogeneity of the S-14 receptor. 4) In view of the very low concentrations of endogenous S-14-like immunoreactivity, the adrenal actions of S-14 and S-28 are probably mediated through an endocrine mechanism.

This article has been cited by other articles:

				A.-M. O'Carroll Localization of Messenger Ribonucleic Acids for Somatostatin Receptor Subtypes (sstr1-5) in the Rat Adrenal Gland J. Histochem. Cytochem., January 1, 2003; 51(1): 55 - 60. [Abstract] [Full Text] [PDF]

				T. J. Gillespie, A. Erenberg, S. Kim, J. Dong, J. E. Taylor, V. Hau, and T. P. Davis Novel Somatostatin Analogs for the Treatment of Acromegaly and Cancer Exhibit Improved In Vivo Stability and Distribution J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 95 - 104. [Abstract] [Full Text]